Table: Wakamoto Pharm -2023/24 parent results

Wakamoto Pharmaceutical

15/05/2024 07:00

May 15 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           7.74            8.66                                 
               (-10.6 pct)     (+3.3 pct)                              
  Operating   loss 195 mln       141 mln                               
  Recurring   loss 161 mln       242 mln                               
                              (+235.7 pct)                             
  Net            108 mln         138 mln                               
               (-21.2 pct)     (-42.0 pct)                             
  EPS           3.13 yen        3.98 yen                               
  Ann Div       3.00 yen        3.00 yen                               
  -Q2 Div          NIL             NIL                                 
  -Q4 Div       3.00 yen        3.00 yen                               
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T